Thyrocare at 50% Premium in Grey Market
Diagnostics company Thyrocare Technologies is said to be commanding a premium of ₹ 220-225 or around 50% over the higher end of its IPO price band of ₹ 420 to ₹ 446 rupees a share in the grey market. The premium has moved up from about ₹ 190 a week ago, and the high interest is on hope that the company too will see a strong debut like its peer Dr Lal PathLabs had seen when it got listed in December, brokers said. Thyrocare’s IPO will hit the capital market on April 27 and will close on April 29. The issue comprises offer for sale of 1.07 crore shares by existing shareholders and promoters.